Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How do patient reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients.
Coyle C, Watson L, Whately-Smith C, Brooke M, Kiltz U, Lubrano E, Queiro R, Trigos D, Brandt-Juergens J, Choy E, D'Angelo S, Delle Sedie A, Dernis E, Wirth T, Guis S, Helliwell P, Ho P, Hueber A, Joven B, Koehm M, Morales CM, Packham J, Pinto Tasende JA, Garcia FJR, Ruyssen-Witrand A, Scrivo R, Twigg S, Welcker M, Soubrier M, Gossec L, Coates LC. Coyle C, et al. Among authors: kiltz u. Rheumatology (Oxford). 2024 Jan 8:kead679. doi: 10.1093/rheumatology/kead679. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38191998 Free article.
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial.
Nash P, Kirkham B, Okada M, Rahman P, Combe B, Burmester GR, Adams DH, Kerr L, Lee C, Shuler CL, Genovese M; SPIRIT-P2 Study Group. Nash P, et al. Lancet. 2017 Jun 10;389(10086):2317-2327. doi: 10.1016/S0140-6736(17)31429-0. Epub 2017 May 24. Lancet. 2017. PMID: 28551073 Clinical Trial.
[Current data on rheumatological care: annual report from the National database (NDB) of the regional collaborative arthritis centres in Germany].
Albrecht K, Thiele K, Alexander T, Aringer M, Eidner T, Henes J, Hoese G, Karberg K, Kiltz U, Krause A, Ochs W, Richter JG, Späthling-Mestekemper S, Steinmüller M, Wassenberg S, Strangfeld A, Callhoff J. Albrecht K, et al. Among authors: kiltz u. Z Rheumatol. 2024 Apr 3. doi: 10.1007/s00393-024-01497-9. Online ahead of print. Z Rheumatol. 2024. PMID: 38568444 German.
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study.
Baraliakos X, Østergaard M, Poddubnyy D, van der Heijde D, Deodhar A, Machado PM, Navarro-Compán V, Hermann KGA, Kishimoto M, Lee EY, Gensler LS, Kiltz U, Eigenmann MF, Pertel P, Readie A, Richards HB, Porter B, Braun J. Baraliakos X, et al. Among authors: kiltz u. Arthritis Rheumatol. 2024 Mar 31. doi: 10.1002/art.42852. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38556921
Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis.
Kiefer D, Schneider L, Braun J, Kiltz U, Kolle N, Andreica I, Tsiami S, Buehring B, Sewerin P, Herbold S, Baraliakos X. Kiefer D, et al. Among authors: kiltz u. Ther Adv Musculoskelet Dis. 2024 Feb 22;16:1759720X231224212. doi: 10.1177/1759720X231224212. eCollection 2024. Ther Adv Musculoskelet Dis. 2024. PMID: 38404654 Free PMC article.
238 results